Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is $1,124.09, with a 24-hour trading volume of $3.91B. The asset's market cap is $1T, after moving -0.72% in the last day.
Tokenized Eli Lilly And Co is trading at $1,130.19, with a tokenized market cap of $43.93M and a 24-hour trading volume of $3.74M. The tokenized asset has moved 2.75% in the past 24 hours.